🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts privately for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.

Some experts stated the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Platform Response and Material Removal

According to the social media company, the service has removed problematic content and prohibited associated hashtags and query recommendations. The company said it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, glowing testimonials and detailed guides for preparing or administering at residence.

Within minutes of joining one community, a seller shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these communities, posts show black plastic packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for Telegram said it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational product not yet approved … may subject patients to possibly serious medical dangers”.